Several agents that were meant to be used in combination with anti-VEGFs have not met expectations. Though new approaches might still be worth pursuing, proper use of currently available treatments, following validated protocols, should have priority, according to Jordi Monés, MD, PhD.
Home / Perspective: Jordi Monés, MD, PhD
Perspective: Jordi Monés, MD, PhD
Other Perspective
Treat and Extend – Practical guide
Treat and Extend (T&E) has gained wide popularity as a proactive, pragmatic, individualized regi
Anti-VEGF therapies for AMD: where are we now?
Where are we now with the spread of these therapies for AMD to prevent blindness?